Spital Judetean De Urgenta Satu Mare

At Spital Judetean De Urgenta Satu Mare, cardiology research focuses on cardiovascular diseases such as atrial fibrillation, acute myocardial infarction, hypertension, and broader atherosclerotic cardiovascular disease. These trials are mainly designed to test new treatments, reduce the risk of stroke and heart events, and improve prevention for people at high cardiovascular risk.

• Stroke and systemic embolism prevention in atrial fibrillation
• New approaches for acute myocardial infarction and recurrent heart attack prevention
• Therapies aimed at lowering heart failure and cardiovascular death risk
• Studies in hypertension and atherosclerotic cardiovascular disease

The site’s work in this area reflects a strong interest in protecting heart and blood vessel health through better treatment options and improved risk reduction.

Research in digestive system diseases centers on liver and bowel conditions, especially non-alcoholic steatohepatitis, metabolic dysfunction-associated steatotic liver disease, and ulcerative colitis. These studies are intended to evaluate whether new therapies can improve liver health, ease intestinal inflammation, and slow disease progression.

• Treatments for non-alcoholic steatohepatitis and related liver fibrosis
• Studies in metabolic dysfunction-associated steatotic liver disease
• New options for people with moderately to severely active ulcerative colitis
• Trials assessing clinical benefit and safety in chronic digestive and liver disorders

These investigations show a growing focus on chronic inflammatory and metabolic liver disease, with the goal of improving long-term outcomes for patients.

The neoplasms portfolio at this hospital includes studies in non-small cell lung cancer and HER2-positive breast cancer. The research is aimed at testing new cancer treatment combinations, supporting recovery after surgery, and improving disease control in patients with advanced or hard-to-treat tumors.

• Therapy evaluation in non-small cell lung cancer, including uncommon genetic subtypes
• Treatment strategies for HER2-positive breast cancer, including advanced disease
• Studies looking at whether new combinations can improve cancer outcomes after standard treatment
• Clinical research focused on better control of tumor progression and treatment effectiveness

This area highlights the site’s involvement in oncology trials that explore more effective and better-targeted cancer care.

Clinical trials in nutritional and metabolic diseases address overweight or obesity, type 2 diabetes, and related metabolic conditions. The main purpose is to assess whether new therapies can support weight reduction, improve metabolic health, and lower the risk of complications linked to excess body weight.

• Weight management research in people with overweight or obesity and type 2 diabetes
• Studies examining broader metabolic health and cardiovascular risk reduction
• Trials evaluating how new treatments may support long-term disease control
• Research connecting metabolic disease care with prevention of heart and liver complications

At Spital Judetean De Urgenta Satu Mare, this field complements the cardiology program by addressing common metabolic factors that influence overall health.